On April 16, 2018, the Canadian Agency for Drugs and Technologies in Health (CADTH) announced the release of its strategic plan for 2018-2021 entitled "Transforming How We Manage Health Technologies in Support of Better Health, Better Patient Experience, and Better Value", and a brief summary overview of the plan. The CADTH, a health technology assessment agency, plans to transition to a health technology management agency by "[c]losing the gap between evidence, policy, and practice", "[a]dopting a life-cycle approach to health technology assessment", and "[a]nticipating health system and technology trends, and develop[ing] agile management strategies."

The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.